ISOPP member expertise needed to serve on an ISOPP Task Force reviewing / endorsing the ADDIKD draft guideline. 

ISOPP has been invited by the NSW Cancer Institute to review/endorse the eviQ ‘Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD)’ draft guideline.

Are you available over the next two weeks? This open consultation will close at midnight (AEST) on May 31, 2022 and the Task Force will work according to our endorsement policy (https://www.isopp.org/education-resources/guideline-endorsement).  

Email services@isopp.org by Tuesday, May 17, if you would like to serve on this time-limited opportunity.